{"id":"https://openalex.org/W2113605807","doi":"https://doi.org/10.3109/10428194.2011.628061","title":"Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies","display_name":"Maintenance rituximab in follicular non-Hodgkin lymphoma: facts and controversies","publication_year":2011,"publication_date":"2011-09-29","ids":{"openalex":"https://openalex.org/W2113605807","doi":"https://doi.org/10.3109/10428194.2011.628061","mag":"2113605807","pmid":"https://pubmed.ncbi.nlm.nih.gov/21958083"},"language":"en","primary_location":{"id":"doi:10.3109/10428194.2011.628061","doi":"https://doi.org/10.3109/10428194.2011.628061","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428194.2011.628061","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102912587","display_name":"Chadi Nabhan","orcid":"https://orcid.org/0000-0003-1740-299X","observed_orcids":["https://orcid.org/0000-0003-1740-299X"]},"institutions":[{"id":"https://openalex.org/I2801579017","display_name":"Advocate Lutheran General Hospital","ror":"https://ror.org/04c8vnp90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801579017","https://openalex.org/I4210088488"]},{"id":"https://openalex.org/I4210149405","display_name":"Oncology Specialists","ror":"https://ror.org/046vm5p14","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210149405"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chadi Nabhan","raw_affiliation_strings":["Department of Medicine, Advocate Lutheran General Hospital, Park Ridge, IL, USA. cnabhan@oncmed.net","Oncology Specialists, S. C., Department of Medicine, Division of Hematology/Oncology, Advocate Lutheran General Hospital, Park Ridge, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Advocate Lutheran General Hospital, Park Ridge, IL, USA. cnabhan@oncmed.net","institution_ids":["https://openalex.org/I2801579017"]},{"raw_affiliation_string":"Oncology Specialists, S. C., Department of Medicine, Division of Hematology/Oncology, Advocate Lutheran General Hospital, Park Ridge, IL, USA","institution_ids":["https://openalex.org/I2801579017","https://openalex.org/I4210149405"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005159945","display_name":"Sonali M. Smith","orcid":"https://orcid.org/0000-0002-9893-4949","observed_orcids":["https://orcid.org/0000-0002-9893-4949"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonali M. Smith","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, University of Chicago, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, University of Chicago, Chicago, IL, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069054551","display_name":"Brad S. Kahl","orcid":"https://orcid.org/0000-0003-0459-6609","observed_orcids":["https://orcid.org/0000-0003-0459-6609"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad S. Kahl","raw_affiliation_strings":["Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology/Oncology, University of Wisconsin, Madison, WI, USA","institution_ids":["https://openalex.org/I135310074"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5102912587"],"corresponding_institution_ids":["https://openalex.org/I2801579017","https://openalex.org/I4210149405"],"apc_list":null,"apc_paid":null,"fwci":0.1636,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.1562753,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"53","issue":"5","first_page":"770","last_page":"778"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.9190000295639038},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9200000166893005},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.9190000295639038},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.878000020980835},{"id":"https://openalex.org/keywords/relapsed-lymphoma","display_name":"relapsed lymphoma","score":0.8389999866485596},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.9570000171661377},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.9544836282730103},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.8591017723083496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7809120416641235},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.6550882458686829},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6108556985855103},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5601539611816406},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.41804713010787964},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.41158726811408997},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3923725485801697},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3568490743637085},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.1916584074497223},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.15568947792053223}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008224","descriptor_name":"Lymphoma, Follicular","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.3109/10428194.2011.628061","doi":"https://doi.org/10.3109/10428194.2011.628061","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428194.2011.628061","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:21958083","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21958083","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W1540507981","https://openalex.org/W1692975962","https://openalex.org/W1700709632","https://openalex.org/W1915689252","https://openalex.org/W1965723348","https://openalex.org/W1972000000","https://openalex.org/W1978235999","https://openalex.org/W1986290856","https://openalex.org/W1994630947","https://openalex.org/W2000635340","https://openalex.org/W2005790431","https://openalex.org/W2032767651","https://openalex.org/W2034513868","https://openalex.org/W2053683902","https://openalex.org/W2061272096","https://openalex.org/W2075135318","https://openalex.org/W2075141373","https://openalex.org/W2087170752","https://openalex.org/W2101141816","https://openalex.org/W2101648653","https://openalex.org/W2114233385","https://openalex.org/W2117541762","https://openalex.org/W2121470615","https://openalex.org/W2123236288","https://openalex.org/W2126027842","https://openalex.org/W2127749132","https://openalex.org/W2135321054","https://openalex.org/W2138404218","https://openalex.org/W2141696964","https://openalex.org/W2142492861","https://openalex.org/W2144016324","https://openalex.org/W2145604368","https://openalex.org/W2153665789","https://openalex.org/W2154643481","https://openalex.org/W2155724413","https://openalex.org/W2156522119","https://openalex.org/W2159982513","https://openalex.org/W2161225854","https://openalex.org/W2161758234","https://openalex.org/W2168750246","https://openalex.org/W2171796002","https://openalex.org/W2175384117","https://openalex.org/W2270766368","https://openalex.org/W2400288892","https://openalex.org/W2551016480","https://openalex.org/W2555451338","https://openalex.org/W2562994716","https://openalex.org/W2567574870"],"related_works":["https://openalex.org/W2736355019","https://openalex.org/W2941069525","https://openalex.org/W2944081921","https://openalex.org/W2126812260","https://openalex.org/W2045661607","https://openalex.org/W2110012164","https://openalex.org/W2070270883","https://openalex.org/W1845110614","https://openalex.org/W2396893803","https://openalex.org/W2120028739"],"abstract_inverted_index":{"The":[0],"advent":[1],"of":[2,18,27,84,124],"rituximab,":[3],"a":[4,82],"chimeric":[5],"monoclonal":[6],"antibody":[7],"against":[8],"CD20,":[9],"has":[10,22,41],"arguably":[11],"improved":[12],"and":[13,21,29,37,76,97,105,130],"changed":[14],"the":[15,45,78,116,121,134],"natural":[16],"history":[17],"non-Hodgkin":[19],"lymphoma":[20,129],"become":[23],"an":[24],"essential":[25],"component":[26],"front-line":[28,75],"relapsed":[30,79],"disease":[31],"treatment":[32],"strategies.":[33],"Given":[34],"its":[35],"tolerability":[36],"long":[38],"half-life,":[39],"rituximab":[40,64,89,126],"been":[42],"investigated":[43],"in":[44,48,57,60,74,77,127,147],"maintenance":[46,63,125],"setting":[47,80],"follicular":[49,128],"lymphoma.":[50],"Several":[51],"landmark":[52],"studies":[53],"have":[54],"demonstrated":[55],"improvement":[56],"progression-free":[58],"survival":[59],"patients":[61],"receiving":[62],"compared":[65],"to":[66,120,132],"those":[67],"observed.":[68],"These":[69],"favorable":[70],"results":[71],"were":[72,95],"witnessed":[73],"using":[81,144],"variety":[83],"induction":[85],"programs":[86],"such":[87],"as":[88],"monotherapy":[90],"or":[91],"chemoimmunotherapy.":[92],"Importantly,":[93],"toxicities":[94],"predictable":[96],"manageable.":[98],"Despite":[99],"these":[100],"encouraging":[101],"results,":[102],"many":[103],"vital":[104],"practical":[106],"questions":[107,137],"remain":[108],"unanswered.":[109],"In":[110],"this":[111,145],"review,":[112],"we":[113],"critically":[114],"analyze":[115],"data":[117],"that":[118],"led":[119],"widespread":[122],"use":[123],"attempt":[131],"answer":[133],"most":[135],"important":[136],"facing":[138],"practicing":[139],"oncologists":[140],"when":[141],"deciding":[142],"on":[143],"approach":[146],"their":[148],"patients.":[149]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}